class name | count |
---|---|
asterids | 321 |
rosids | 278 |
eudicotyledons | 91 |
Magnoliophyta | 85 |
Liliopsida | 71 |
Spermatophyta | 28 |
Euphyllophyta | 13 |
Embryophyta | 2 |
class name | count |
---|---|
Asteraceae
![]() |
103 |
Fabaceae
![]() |
101 |
Brassicaceae
![]() |
58 |
Lamiaceae
![]() |
45 |
Apiaceae
![]() |
44 |
Solanaceae
![]() |
28 |
Piperaceae
![]() |
27 |
Cactaceae
![]() |
25 |
Poaceae
![]() |
24 |
Lauraceae
![]() |
21 |
Rosaceae
![]() |
18 |
Rutaceae
![]() |
17 |
Rubiaceae
![]() |
16 |
Crassulaceae
![]() |
14 |
Plantaginaceae
![]() |
14 |
Malvaceae
![]() |
13 |
Myrtaceae
![]() |
12 |
Oleaceae
![]() |
12 |
Pinaceae
![]() |
11 |
Ranunculaceae
![]() |
10 |
br08003 Category | # of metabolite |
---|---|
Sinapate derivatives | 9 |
Paracoumaryl alcohol derivatives | 4 |
Coniferyl alcohol derivatives | 8 |
Others | 10 |
Tyramine derivatives | 7 |
Caffeate derivatives | 7 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
---|---|---|---|---|---|---|---|
C00002760
![]() |
3-Hydroxy-3-methylglutaryl CoA
|
CHEMBL1794644
|
C008047
|
No. 310 |
![]() |
||
C00002775
![]() |
Coenzyme A
/ Palmityl-CoA / Palmitoyl CoA |
D010171
|
6 / 0 | No. 310 |
![]() |
||
C00002778
![]() |
Sinapoyl-CoA
|
No. 310 |
![]() |
||||
C00043990
![]() |
Sinapic acid ethyl ester
|
No. 310 |
![]() |
||||
C00007337
![]() |
3,5-Dicaffeoylquinic methyl ester
/ (-)-3,5-Dicaffeoylquinic methyl ester |
CHEMBL462817
CHEMBL463337 CHEMBL2048502 |
6 / 5 / 4 | No. 310 |
![]() |
||
C00007611
![]() |
4-O-Galloylchlorogenic acid
|
CHEMBL458307
|
No. 310 |
![]() |
|||
C00018882
![]() |
Koaburaside
|
CHEMBL513117
|
2 / 4 / 2 | No. 310 |
![]() |
||
C00000614
![]() |
Coniferaldehyde
/ Coniferyl aldehyde / 4-Hydroxy-3-methoxycinnamaldehyde |
CHEMBL242529
CHEMBL1956165 |
C075384
|
1 / 1 / 1 | No. 310 |
![]() |
|
C00039440
![]() |
Carpacin
|
No. 310 |
![]() |
||||
C00002728
![]() |
4-O-Cinnamoyl quinic acid
|
No. 310 |
![]() |
||||
C00000620
![]() |
Syringenin
|
CHEMBL1800816
|
No. 310 |
![]() |
|||
C00038240
![]() |
3-Methoxytyramine
|
CHEMBL1160785
|
C001746
|
7 / 5 / 5 | No. 310 |
![]() |
|
C00029546
![]() |
Isoelemicin
/ (E)-Isoelemicin |
CHEMBL121548
|
No. 310 |
![]() |
|||
C00035949
![]() |
Isoferulic acid
|
CHEMBL233295
|
C008180
|
5 / 9 / 6 | 0 / 1 | No. 310 |
![]() |
C00031384
![]() |
4-Hydroxycinnamate
|
CHEMBL66879
CHEMBL2336752 |
23 / 13 / 18 | No. 310 |
![]() |
||
C00031469
![]() |
Caffeic acid
|
CHEMBL145
CHEMBL1320034 |
68 / 64 / 63 | No. 310 |
![]() |
||
C00035903
![]() |
trans-p-Coumaroyl beta-D-glucopyranoside
/ (-)-trans-p-Coumaroyl beta-D-glucopyranoside |
CHEMBL464612
|
No. 310 |
![]() |
|||
C00035131
![]() |
Potassium lespedezate
|
CHEMBL406416
CHEMBL260171 CHEMBL405894 CHEMBL406019 |
No. 310 |
![]() |
|||
C00035095
![]() |
1-O-Sinapoyl-beta-D-glucose
|
No. 310 |
![]() |
||||
C00034298
![]() |
Dopamine
|
CHEMBL59
|
D004298
|
69 / 40 / 56 | 51 / 52 | No. 310 |
![]() |
C00033554
![]() |
3-(3,4-Dihydroxyphenyl)-1-propanol
|
CHEMBL485747
|
7 / 5 / 4 | No. 310 |
![]() |
||
C00032657
![]() |
Cactine
/ Anhalin / Anhaline / Hordenine |
CHEMBL505789
|
C007964
|
1 / 0 / 0 | No. 314 |
![]() |
|
C00035932
![]() |
E-Ferulic acid
/ (E)-Ferulic acid / trans-Ferulic acid / 4-Hydroxy-3-methoxy-(E)-cinnamic acid |
CHEMBL32749
|
110 / 52 / 40 | No. 314 |
![]() |
||
C00002717
![]() |
Heriguard
/ Chlorogenic acid / 3-O-Caffeoylquinic acid |
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
D002726
|
30 / 19 / 22 | 37 / 9 | No. 314 |
![]() |
C00035939
![]() |
Ferulic acid
/ 3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid |
CHEMBL32749
|
C004999
|
110 / 52 / 40 | 16 / 6 | No. 314 |
![]() |
C00030807
![]() |
N-Methylmescaline
|
CHEMBL100531
|
No. 314 |
![]() |
|||
C00030769
![]() |
Mescaline
|
CHEMBL26687
|
D008635
|
3 / 0 / 0 | 0 / 1 | No. 314 |
![]() |
C00029948
![]() |
Isoasarone
|
No. 314 |
![]() |
||||
C00002724
![]() |
4-p-Coumaroylquinic acid
|
No. 314 |
![]() |
||||
C00029558
![]() |
3,4,5-Trimethoxycinnamyl alcohol
/ 3',4',5'-Trimethoxycinnamyl alcohol |
No. 314 |
![]() |
||||
C00035951
![]() |
5-Hydroxyferulic acid
|
C071744
|
No. 314 |
![]() |
|||
C00039428
![]() |
Myristicin
|
CHEMBL481044
|
C005246
|
6 / 4 / 2 | 2 / 0 | No. 314 |
![]() |
C00029541
![]() |
2,4,5-Trimethoxycinnamaldehyde
|
CHEMBL1163242
|
No. 314 |
![]() |
|||
C00002730
![]() |
Methyl chlorogenate
/ Methyl 5-O-caffeoylquinate / Chlorogenic acid methyl ester |
CHEMBL416955
CHEMBL596924 CHEMBL1765881 CHEMBL1765882 CHEMBL2048503 CHEMBL2349427 |
6 / 5 / 4 | No. 314 |
![]() |
||
C00029540
![]() |
2,4,5-Trimethoxystyrene
|
CHEMBL488200
|
C056257
|
No. 314 |
![]() |
||
C00029511
![]() |
Erigeside II
/ 2,6-Dimethoxy-4-(2-propenyl)phenyl beta-D-glucoside |
No. 314 |
![]() |
||||
C00042501
![]() |
(E)-Cinnamaldehyde
|
CHEMBL293492
|
98 / 49 / 42 | No. 314 |
![]() |
||
C00042735
![]() |
Styrene
|
CHEMBL285235
|
D020058
|
5 / 6 / 4 | 27 / 9 | No. 314 |
![]() |
C00042739
![]() |
(E)-Anethol
/ trans-Anethol / trans-1-(4-Methoxyphenyl)-1-propene |
CHEMBL452630
CHEMBL1468832 |
6 / 21 / 49 | No. 314 |
![]() |
||
C00044603
![]() |
1'-Acetoxyeugenol acetate
|
CHEMBL111484
|
C057996
|
0 / 1 | No. 314 |
![]() |
|
C00044753
![]() |
trans-p-Coumaryl diacetate
|
CHEMBL444328
|
No. 314 |
![]() |
|||
C00049091
![]() |
Candicine
|
CHEMBL1186075
|
No. 314 |
![]() |
|||
C00007269
![]() |
4,5-Di-O-caffeoylquinic acid
/ 4,5-Di-O-trans-caffeoyl quinic acid |
CHEMBL358821
CHEMBL149674 CHEMBL177126 CHEMBL249448 CHEMBL453276 CHEMBL453537 CHEMBL1972460 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007462
![]() |
1,2-Di-O-(E)-caffeoyl-beta-D-glucopyranose
|
No. 461 |
![]() |
||||
C00007361
![]() |
3,4-Dicaffeoyl quinic acid
/ (-)-3,4-Dicaffeoyl quinic acid |
CHEMBL464371
CHEMBL516541 |
No. 461 |
![]() |
|||
C00007283
![]() |
3,5-Caffeoyl quinic acid
/ 3,5-di-O-Caffeoylquinic acid / (-)-3,5-Dicaffeoyl quinic acid |
CHEMBL441250
CHEMBL249447 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007281
![]() |
3,5-di-O-caffeate
/ sochlorogenic acid a / 3,5-Dicaffeoylquinic acid |
CHEMBL441250
CHEMBL249447 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007280
![]() |
Isochlorogenic acid b
/ 3,4-Dicaffeoylquinic acid |
CHEMBL358821
CHEMBL149674 CHEMBL177126 CHEMBL249448 CHEMBL453276 CHEMBL453537 CHEMBL1972460 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007270
![]() |
sochlorogenic acid c
/ 4,5-Dicaffeoylquinic acid |
CHEMBL358821
CHEMBL149674 CHEMBL177126 CHEMBL249448 CHEMBL453276 CHEMBL453537 CHEMBL1972460 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007264
![]() |
3,4-di-O-Caffeoylquinic acid
/ (-)-4,5-Dicaffeoyl quinic acid |
CHEMBL358821
CHEMBL149674 CHEMBL177126 CHEMBL249448 CHEMBL453276 CHEMBL453537 CHEMBL1972460 |
2 / 0 / 0 | No. 461 |
![]() |
||
C00007257
![]() |
4-Coumaroyl-CoA
/ p-Coumaroyl-CoA |
CHEMBL250086
|
No. 461 |
![]() |
|||
C00007258
![]() |
Caffeoyl-CoA
|
C058645
|
No. 461 |
![]() |
|||
C00007259
![]() |
Cinnamoyl-CoA
|
No. 461 |
![]() |
||||
C00007260
![]() |
3'-Dephospho-CoA
|
C015787
|
No. 461 |
![]() |
|||
C00007263
![]() |
D-Coenzyme A
/ Coenzyme ASH |
CHEMBL1213327
CHEMBL1623949 |
D003065
|
4 / 2 / 2 | No. 461 |
![]() |
|
C00029480
![]() |
Syringin
|
CHEMBL250872
|
C028305
|
1 / 0 / 0 | 0 / 1 | No. 518 |
![]() |
C00034768
![]() |
trans-p-Feruloyl beta-D-glucopyranoside
/ (-)-trans-p-Feruloyl beta-D-glucopyranoside |
CHEMBL1778418
|
No. 518 |
![]() |
|||
C00044459
![]() |
1'-Acetoxychavicol acetate
|
CHEMBL323727
CHEMBL359887 CHEMBL414656 |
No. 518 |
![]() |
|||
C00032578
![]() |
Tyramine
|
CHEMBL11608
|
D014439
|
23 / 11 / 6 | 6 / 9 | No. 518 |
![]() |
C00002751
![]() |
Methyl-3-O-feruloylquinate
|
No. 518 |
![]() |
||||
C00032590
![]() |
4-Hydroxybenzyl cyanide
/ p-Hydroxyphenylacetonitrile / 4-Hydroxy-benzeneacetonitrile |
C026914
|
No. 518 |
![]() |
|||
C00044046
![]() |
Sinapic acid methyl ester
/ trans-Sinapic acid methyl ester |
CHEMBL146713
|
No. 518 |
![]() |
|||
C00043178
![]() |
3,4-Dimethoxycinnamic acid methyl ester
|
CHEMBL17647
|
No. 518 |
![]() |
|||
C00034818
![]() |
1-Caffeoyl-beta-D-glucose
|
CHEMBL482242
|
No. 518 |
![]() |
|||
C00044928
![]() |
Caffeic aldehyde
/ 3,4-Dihydroxycinnamaldehyde |
CHEMBL17291
|
1 / 1 / 1 | No. 518 |
![]() |
||
C00049080
![]() |
5-O-Caffeoylshikimic acid
|
C036792
|
No. 518 |
![]() |
|||
C00002723
![]() |
4-O-p-Coumaroylquinic acid
|
No. 518 |
![]() |
||||
C00002733
![]() |
3-Caffeoylquinic acid methyl ester
|
CHEMBL416955
CHEMBL596924 CHEMBL1765881 CHEMBL1765882 CHEMBL2048503 CHEMBL2349427 |
6 / 5 / 4 | No. 518 |
![]() |
||
C00029520
![]() |
Coniferin
/ Coniferoside |
CHEMBL459056
|
C016316
|
2 / 0 / 0 | No. 518 |
![]() |
|
C00029481
![]() |
Eleutheroside B
|
CHEMBL250872
|
C028305
|
1 / 0 / 0 | 0 / 1 | No. 518 |
![]() |
C00033559
![]() |
4-Allyl-pyrocatechol
|
CHEMBL111134
|
C051268
|
8 / 0 | No. 518 |
![]() |
|
C00000010
![]() |
Isoeugenol
|
CHEMBL193598
CHEMBL445206 CHEMBL2135887 |
C036643
|
93 / 36 / 31 | 44 / 1 | No. 678 |
![]() |
C00033999
![]() |
4-Allylcatechol
|
CHEMBL111134
|
C051268
|
8 / 0 | No. 678 |
![]() |
|
C00021006
![]() |
Leonuriside A
/ 2,6-Dimethoxy-p-hydroquinone 1-O-beta-glucopyranoside |
CHEMBL464406
|
2 / 4 / 2 | No. 678 |
![]() |
||
C00034384
![]() |
N-Methyl-3,4,5-trihydroxyphenethylamine
|
No. 678 |
![]() |
||||
C00041162
![]() |
p-Coumaryl alcohol
|
CHEMBL109034
|
C041474
|
No. 678 |
![]() |
||
C00031878
![]() |
Z-Cinnamic acid
/ cis-Cinnamic acid |
CHEMBL27246
|
5 / 2 / 2 | No. 678 |
![]() |
||
C00040779
![]() |
Apiol
/ Apiole / Parsley apiole |
CHEMBL1560118
|
3 / 0 / 1 | No. 678 |
![]() |
||
C00031751
![]() |
Cinnamic acid
/ .beta-Phenylacrylic acid |
CHEMBL27246
|
C029010
|
5 / 2 / 2 | 16 / 2 | No. 678 |
![]() |
C00039279
![]() |
Sarisan
/ Asaricin / 1-Allyl-2-methoxy-4,5-methylene-dioxybenzene |
C056048
|
No. 678 |
![]() |
|||
C00036467
![]() |
E)-3,4-Dimethoxycinnamic acid
/ 3,4-Dimethoxy-trans-cinnamic acid |
CHEMBL320295
|
10 / 11 / 12 | No. 678 |
![]() |
||
C00002727
![]() |
4-O-Cinnamoylquinic acid
|
No. 678 |
![]() |
||||
C00011172
![]() |
Methyl 4-O-galloylchlorogenate
/ (-)-Methyl 4-O-galloylchlorogenate |
CHEMBL459400
|
No. 678 |
![]() |
|||
C00030167
![]() |
2,3,6-Trimethoxy-5-(1E)-1-propenylphenol
|
CHEMBL501754
|
No. 678 |
![]() |
|||
C00018883
![]() |
Ficuglucoside
/ 1beta-(3-Hydroxy-4,5-dimethoxyphenyl)-O-glucopyranoside |
CHEMBL2332683
|
No. 723 |
![]() |
|||
C00044434
![]() |
Sinapine
/ Sinapoylcholine |
C005685
|
No. 723 |
![]() |
|||
C00002739
![]() |
Ethyl 4-O-caffeoylquinate
|
CHEMBL485994
|
No. 723 |
![]() |
|||
C00031898
![]() |
p-Tyrosol
/ 4-(2-Hydroxyethyl)phenol / p-Hydroxyphenethyl alcohol / 2-(4-Hydroxyphenyl)ethanol |
CHEMBL53566
|
C011867
|
6 / 3 / 5 | No. 723 |
![]() |
|
C00042219
![]() |
(E)-Cinnamic alcohol
/ trans-Cinnamyl alcohol |
CHEMBL118958
CHEMBL324794 |
4 / 2 / 1 | No. 723 |
![]() |
||
C00035486
![]() |
Methyl 6-O-p-trans-coumaroyl-beta-D-glucopyranoside
|
No. 723 |
![]() |
||||
C00042628
![]() |
Cinnamaldehyde
|
CHEMBL293492
|
C012843
|
98 / 49 / 42 | 151 / 23 | No. 723 |
![]() |
C00002715
![]() |
Isochlorogenic acid
|
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
30 / 19 / 22 | No. 723 |
![]() |
||
C00001421
![]() |
5-Hydroxyconiferyl alcohol
|
No. 723 |
![]() |
||||
C00036458
![]() |
Sinapic acid
|
CHEMBL109341
|
C073734
|
5 / 5 / 5 | 0 / 5 | No. 723 |
![]() |
C00036457
![]() |
(E)-Sinapic acid
/ trans-Sinapic acid / 4-Hydroxy-3,5-dimethoxy-(E)-cinnamic acid |
CHEMBL109341
|
5 / 5 / 5 | No. 723 |
![]() |
||
C00001419
![]() |
Sinapaldehyde
/ Sinapic aldehyde |
CHEMBL225067
|
C075386
|
No. 723 |
![]() |
||
C00038791
![]() |
Eugenol
|
CHEMBL42710
|
D005054
|
103 / 45 / 36 | 152 / 28 | No. 904 |
![]() |
C00026316
![]() |
3,4,5-Trimethoxyphenyl beta-D-glucopyranoside
|
CHEMBL469618
|
No. 904 |
![]() |
|||
C00000152
![]() |
Z-Isoeugenol
|
CHEMBL193598
CHEMBL445206 CHEMBL2135887 |
93 / 36 / 31 | No. 904 |
![]() |
||
C00000170
![]() |
E-Isoeugenol
|
CHEMBL193598
CHEMBL445206 CHEMBL2135887 |
93 / 36 / 31 | No. 904 |
![]() |
||
C00034743
![]() |
1-O-Feruloyl-beta-D-glucopyranose
|
No. 904 |
![]() |
||||
C00029961
![]() |
Elemicin
|
CHEMBL458690
|
C002135
|
No. 904 |
![]() |
||
C00038786
![]() |
Dihydroconiferyl alcohol
|
No. 904 |
![]() |
||||
C00000580
![]() |
2-Methoxy-4-(3-methoxy-1-propenyl)-phenol
|
No. 904 |
![]() |
||||
C00002729
![]() |
1-Caffeoyl-4-deoxyquinic acid
|
No. 904 |
![]() |
||||
C00000615
![]() |
Isoferulaldehyde
|
CHEMBL53781
|
2 / 2 / 11 | No. 904 |
![]() |
||
C00029528
![]() |
trans-p-Sinapoyl beta-D-glucopyranoside
|
No. 936 |
![]() |
||||
C00029533
![]() |
alpha-Asarone
|
CHEMBL333306
CHEMBL477752 |
2 / 1 / 1 | No. 936 |
![]() |
||
C00001435
![]() |
5-Hydroxyconiferyl aldehyde
|
No. 936 |
![]() |
||||
C00029515
![]() |
Dihydrosyringin
|
CHEMBL2332681
|
No. 936 |
![]() |
|||
C00000621
![]() |
Sinapyl alcohol
|
CHEMBL1800816
|
No. 936 |
![]() |
|||
C00001417
![]() |
Sinapinaldehyde
|
CHEMBL225067
|
No. 936 |
![]() |
|||
C00029532
![]() |
beta-Asarone
|
CHEMBL333306
CHEMBL477752 |
2 / 1 / 1 | No. 936 |
![]() |
||
C00027432
![]() |
Taxicatin
|
No. 936 |
![]() |
||||
C00042101
![]() |
trans-p-Coumaryl alcohol
|
CHEMBL109034
|
No. 1114 |
![]() |
|||
C00042777
![]() |
Tuberin
/ Tuberine |
CHEMBL1967986
|
No. 1114 |
![]() |
|||
C00042758
![]() |
Anethole
|
CHEMBL452630
CHEMBL1468832 |
C006578
|
6 / 21 / 49 | 16 / 13 | No. 1114 |
![]() |
C00032635
![]() |
Gastrodigenin
/ 4-Methylolphenol / p-Hydroxybenzyl alcohol / 4-Hydroxybenzyl alcohol |
CHEMBL202132
|
C018966
|
6 / 3 / 4 | 0 / 2 | No. 1114 |
![]() |
C00001408
![]() |
2,3-Dimethoxy-5-(1E)-1-propenylphenol
|
CHEMBL489518
|
No. 1114 |
![]() |
|||
C00044457
![]() |
Galangal acetate
/ 1'-Acetoxychavicol acetate / 1'S-1'-Acetoxychavicol acetate |
CHEMBL323727
CHEMBL359887 CHEMBL414656 |
C047948
|
27 / 1 | No. 1114 |
![]() |
|
C00042774
![]() |
4-Methoxycinnamaldehyde
/ p-Methoxycinnamaldehyde |
CHEMBL452173
|
No. 1114 |
![]() |
|||
C00047668
![]() |
Caffeyl alcohol
|
CHEMBL1321891
|
3 / 0 / 1 | No. 1114 |
![]() |
||
C00031551
![]() |
trans-Cinnamate
/ trans-Cinnamic acid |
CHEMBL27246
|
5 / 2 / 2 | No. 1114 |
![]() |
||
C00000289
![]() |
trans-Coniferyl alcohol
|
CHEMBL501870
CHEMBL2088631 |
No. 1127 |
![]() |
|||
C00013592
![]() |
cis-Linalool oxide
|
CHEMBL29660
CHEMBL282731 CHEMBL63592 CHEMBL397730 |
14 / 17 / 50 | No. 1127 |
![]() |
||
C00032613
![]() |
Chavicol
/ p-Hydroxyallylbenzene |
CHEMBL108862
|
No. 1127 |
![]() |
|||
C00037931
![]() |
p-Methoxydopamine
/ 3-Hydroxy-4-methoxyphenethylamine |
CHEMBL1492473
|
C031065
|
7 / 5 / 5 | No. 1127 |
![]() |
|
C00037495
![]() |
Dihydroferulic acid
|
CHEMBL387842
|
No. 1127 |
![]() |
|||
C00032376
![]() |
N-Methyltyramine
|
C036244
|
No. 1127 |
![]() |
|||
C00000288
![]() |
Coniferyl alcohol
|
CHEMBL501870
CHEMBL2088631 |
C010559
|
No. 1127 |
![]() |
||
C00002718
![]() |
5-Caffeoyl quinic acid
/ (+)-5-Caffeoyl quinic acid |
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
30 / 19 / 22 | No. 1127 |
![]() |
||
C00034325
![]() |
N-Methyldopamine
|
CHEMBL31088
|
D003846
|
23 / 25 / 52 | 1 / 0 | No. 1366 |
![]() |
C00007336
![]() |
1,5-Di-O-caffeoylquinic acid
|
CHEMBL431948
CHEMBL487258 CHEMBL478574 CHEMBL1213299 CHEMBL2105478 CHEMBL2356300 |
6 / 5 / 7 | No. 1366 |
![]() |
||
C00034327
![]() |
N,N-Dimethyldopamine
|
CHEMBL347228
|
C041923
|
No. 1366 |
![]() |
||
C00002752
![]() |
methyl 4-O-coumaroylquinate
|
CHEMBL2349428
|
No. 1366 |
![]() |
|||
C00002743
![]() |
Butyl chlorogenate
|
CHEMBL1087756
|
No. 1366 |
![]() |
|||
C00033558
![]() |
3-Hydroxytyrosol
/ 3,4-Dihydroxyphenethyl alcohol |
CHEMBL1950045
|
C005975
|
26 / 4 | No. 1366 |
![]() |
|
C00002776
![]() |
Feruloyl-CoA
|
No. 1366 |
![]() |
||||
C00042126
![]() |
4-Hydroxycinnamaldehyde
/ p-Hydroxycinnamaldehyde |
CHEMBL431836
CHEMBL1956164 |
3 / 4 / 3 | No. 1852 |
![]() |
||
C00002736
![]() |
5-Caffeoylquinic acid methyl ester
|
CHEMBL416955
CHEMBL596924 CHEMBL1765881 CHEMBL1765882 CHEMBL2048503 CHEMBL2349427 |
6 / 5 / 4 | No. 1852 |
![]() |
||
C00042132
![]() |
trans-p-Hydroxycinnamaldehyde
|
CHEMBL431836
CHEMBL1956164 |
3 / 4 / 3 | No. 1852 |
![]() |
||
C00000619
![]() |
Varamol 106
/ 4-Vinyl guaiacol |
C014245
|
No. 1852 |
![]() |
|||
C00040946
![]() |
Dillapiole
|
CHEMBL470874
|
C059115
|
1 / 0 / 0 | No. 1852 |
![]() |
|
C00029504
![]() |
Icariside H1
/ Juniperoside / (-)-Icariside H1 / (-)-Juniperoside |
No. 1852 |
![]() |
||||
C00002773
![]() |
Acetoacetyl-CoA
|
C010667
|
No. 1917 |
![]() |
|||
C00002721
![]() |
3-Ferulylquinic acid
/ 3-O-Feruloylquinic acid |
No. 1917 |
![]() |
||||
C00002714
![]() |
Neochlorogenic acid
/ 5-Caffeoylquinic acid / 5-O-Caffeoylquinic acid |
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
30 / 19 / 22 | No. 1917 |
![]() |
||
C00002737
![]() |
Methyl-4-O-caffeoylquinate
/ (+)-Methyl-4-O-caffeoylquinate |
CHEMBL2349426
|
No. 1917 |
![]() |
|||
C00002762
![]() |
Acetyl-CoA
|
D000105
|
4 / 0 | No. 1917 |
![]() |
||
C00031422
![]() |
o-Coumaric acid
|
CHEMBL52564
|
C085894
|
17 / 6 / 17 | No. 1979 |
![]() |
|
C00000613
![]() |
4-Hydroxy-3-methoxy-trans-cinnamaldehyde
|
CHEMBL242529
CHEMBL1956165 |
1 / 1 / 1 | No. 1979 |
![]() |
||
C00031420
![]() |
trans-p-Coumaric acid
/ trans-p-Hydroxycinnamic acid |
CHEMBL66879
CHEMBL2336752 |
23 / 13 / 18 | No. 1979 |
![]() |
||
C00031014
![]() |
3,4,5-Trimethoxybenzyl alcohol
|
No. 1979 |
![]() |
||||
C00032375
![]() |
4-Ethylphenol
|
CHEMBL108475
|
C042291
|
3 / 0 / 0 | 3 / 0 | No. 2320 |
![]() |
C00042390
![]() |
Cinnamyl alcohol
|
CHEMBL118958
CHEMBL324794 |
C020722
|
4 / 2 / 1 | 32 / 1 | No. 2320 |
![]() |
C00035187
![]() |
Potassium isolespedezate
|
CHEMBL406416
CHEMBL260171 CHEMBL405894 CHEMBL406019 |
No. 2320 |
![]() |
|||
C00037855
![]() |
Vanilacetic acid
/ Homovanillic acid / 3-Methoxy-4-hydroxyphenylacetic acid / 4-Hydroxy-3-methoxybenzeneacetic acid |
CHEMBL1562
|
D006719
|
17 / 9 / 7 | 2 / 11 | No. 2320 |
![]() |
C00002725
![]() |
3-O-Coumaroylquinic acid
/ 3-O-p-Coumaroyl quinic acid |
CHEMBL284243
|
No. 2320 |
![]() |
|||
C00002713
![]() |
(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol
/ (E)-4-(3,4-Dimethoxyphenyl)-3-buten-1-ol |
C053776
|
No. 2748 |
![]() |
|||
C00002757
![]() |
Malonyl CoA
|
D008316
|
No. 2748 |
![]() |
|||
C00018703
![]() |
Chicoric acid
|
CHEMBL29660
CHEMBL282731 CHEMBL63592 CHEMBL397730 |
C100435
|
14 / 17 / 50 | No. 2748 |
![]() |
|
C00029334
![]() |
Glucoacetosyringone
|
CHEMBL517838
CHEMBL516755 |
No. 2748 |
![]() |
|||
C00048280
![]() |
Estragol
/ Esdragol / Estragole |
CHEMBL470671
|
C007633
|
10 / 16 / 43 | 3 / 5 | No. 2905 |
![]() |
C00034328
![]() |
3,4,5-Trihydroxyphenethylamine
|
CHEMBL30625
|
C027802
|
1 / 0 | No. 2905 |
![]() |
|
C00031383
![]() |
p-Coumaric acid
|
CHEMBL66879
CHEMBL2336752 |
C032171
|
23 / 13 / 18 | 6 / 1 | No. 2905 |
![]() |
C00002777
![]() |
5-Hydroxyferuloyl-CoA
|
C090959
|
No. 2905 |
![]() |
|||
C00031421
![]() |
cis-p-Coumaric acid
|
CHEMBL66879
CHEMBL2336752 |
23 / 13 / 18 | No. 3071 |
![]() |
||
C00002712
![]() |
3,4-Dimethoxycinnamaldehyde
|
CHEMBL465888
|
No. 3071 |
![]() |
|||
C00031531
![]() |
cis-2,4-Dihydroxycinnamic acid
|
CHEMBL1235981
|
No. 3071 |
![]() |
|||
C00002711
![]() |
Methylisoeugenol
|
CHEMBL465829
CHEMBL1164609 |
No. 3071 |
![]() |
|||
C00007511
![]() |
1,3-Di-O-(E)-Caffeoyl-beta-D-glucopyranose
/ (-)-1,3-Di-O-(E)-Caffeoyl-beta-D-glucopyranose |
No. 3417 |
![]() |
||||
C00007310
![]() |
1,3-Dicaffeoylquinic acid
|
CHEMBL431948
CHEMBL487258 CHEMBL478574 CHEMBL1213299 CHEMBL2105478 CHEMBL2356300 |
6 / 5 / 7 | No. 3417 |
![]() |
||
C00002740
![]() |
Ethyl chlorogenate
|
CHEMBL482232
|
No. 3933 |
![]() |
|||
C00002720
![]() |
4-Caffeoylquinic acid
/ 4-O-Caffeoylquinic acid |
No. 5859 |
![]() |
||||
C00002319
![]() |
Methyl isoeugenol
|
CHEMBL465829
CHEMBL1164609 |
C031050
|
3 / 0 | No. 8319 |
![]() |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000152
C00000619
C00002725
C00002743
C00031531 C00032635 C00037855 C00044457 C00047668 |
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000619
C00000620
C00001408
C00002713
C00002725 C00031531 C00032635 |
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000619
C00000620
C00002713
C00002725
C00031531 C00032635 |
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000152
C00000619
C00000620
C00001408
C00002743 C00037855 |
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000619
C00000620
C00002725
C00007259
C00037855 C00042390 |
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000619
C00001408
C00002725
C00031531
C00032635 C00037855 |
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001408
C00002713
C00002725
C00002743
C00032635 |
847 | CAT | catalase (EC:1.11.1.6) |
C00000619
C00000620
C00001408
C00037855
C00042390 |
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000619
C00001408
C00002725
C00035131
C00037855 |
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001408
C00002713
C00002725
C00002743
C00032635 |
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000619
C00000620
C00002725
C00032635
C00042390 |
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000152
C00000619
C00002740
C00002743
C00002762 |
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000619
C00000620
C00002725
C00037855
C00042390 |
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000619
C00001408
C00029961
C00044457
C00047668 |
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000619
C00000620
C00002713
C00002725
C00031531 |
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000619
C00000620
C00001408
C00002725
C00042390 |
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000619
C00002724
C00002743
C00029961
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000619
C00002724
C00002743
C00029961
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000619
C00001408
C00035131
C00037855
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000619
C00002724
C00002743
C00029961
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000619
C00002740
C00029961
C00037855
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00000152
C00002724
C00002743
C00029961
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000619
C00000620
C00002725
C00042390
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001408
C00002713
C00002725
C00031531
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000619
C00000620
C00002725
C00042390
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000619
C00000620
C00002725
C00042390
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000619
C00000620
C00002725
C00042390
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000619
C00000620
C00002725
C00042390
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000619
C00000620
C00002724
C00042390
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001408
C00002725
C00032635
C00037855
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000619
C00000620
C00002725
C00042390
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000619
C00001408
C00007462
C00035131
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000619
C00000620
C00042390
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000619
C00000620
C00042390
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00002713
C00031531
C00032635
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000619
C00000620
C00042390
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000619
C00000620
C00042390
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000619
C00002724
C00007462
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000619
C00000620
C00042390
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000619
C00000620
C00042390
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000619
C00000620
C00042390
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000619
C00002713
C00029528
|
7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000619
C00000620
C00042390
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000619
C00000620
C00042390
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000619
C00000620
C00042390
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000619
C00000620
C00042390
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002725
C00031531
C00032635
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000619
C00000620
C00042390
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000619
C00001408
C00002725
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000619
C00000620
C00037855
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000619
C00000620
C00042390
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000619
C00000620
C00042390
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001408
C00002725
C00037855
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001408
C00002725
C00032635
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001408
C00002762
C00029961
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00000152
C00002724
C00029961
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002724
C00002743
C00029961
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000619
C00000620
C00042390
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000619
C00002725
C00031531
|
1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00000620
C00002725
C00042390
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001408
C00029504
C00042101
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000619
C00000620
C00042390
|
10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000619
C00000620
C00042390
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001408
C00002725
C00037855
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000619
C00000620
C00042390
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000619
C00000620
C00042390
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00002725
C00031531
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00002725
C00031531
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000619
C00029961
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000152
C00001408
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000619
C00000620
|
29126 | CD274, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1, PDL1 | CD274 molecule |
C00000620
C00002725
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00000619
C00002725
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00002713
C00031531
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000619
C00029528
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002713
C00002725
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00031531
C00037855
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002713
C00031531
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00000619
C00002725
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00000619
C00002725
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002713
C00002725
|
23563 | CHST5, I-GlcNAc-6-ST, I-GlcNAc6ST, glcNAc6ST-3, gn6st-3, hIGn6ST | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 |
C00044457
C00047668
|
4166 | CHST6, MCDC1 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
C00044457
C00047668
|
56548 | CHST7, C6ST-2, GST-5 | carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 (EC:2.8.2.17) |
C00044457
C00047668
|
2953 | GSTT2, GSTT2B | glutathione S-transferase theta 2 (EC:2.5.1.18) |
C00044457
C00047668
|
8520 | HAT1, KAT1 | histone acetyltransferase 1 (EC:2.3.1.48) |
C00044457
C00047668
|
7172 | TPMT | thiopurine S-methyltransferase (EC:2.1.1.67) |
C00044457
C00047668
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000619
C00002724
|
5617 | PRL | prolactin |
C00001408
C00042777
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002725
C00031531
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00000619
C00001408
|
10626 | TRIM16, EBBP | tripartite motif containing 16 |
C00000620
C00002725
|
6343 | SCT | secretin |
C00001408
C00029504
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000619
C00002725
|
1958 | EGR1, AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 | early growth response 1 |
C00002725
C00032635
|
2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00000619
C00002725
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000619
C00002725
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001408
C00001435
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000619
C00002725
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001408
C00001435
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002725
C00031531
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00002725
C00032635
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001408
C00001435
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001408
C00001435
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001408
C00001435
|
3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00000619
C00002725
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002725
C00002743
|
3251 | HPRT1, HGPRT, HPRT | hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) |
C00002725
C00037855
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002743
C00031531
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002740
C00029961
|
23621 | BACE1, ASP2, BACE, HSPC104 | beta-site APP-cleaving enzyme 1 (EC:3.4.23.46) |
C00002743
|
2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00002725
|
3304 | HSPA1B, HSP70-1B, HSP70-2 | heat shock 70kDa protein 1B |
C00002725
|
10553 | HTATIP2, CC3, SDR44U1, TIP30 | HIV-1 Tat interactive protein 2, 30kDa (EC:1.1.1.-) |
C00002725
|
27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00002725
|
3429 | IFI27, FAM14D, ISG12, ISG12A, P27 | interferon, alpha-inducible protein 27 |
C00002725
|
10964 | IFI44L, C1orf29 | interferon-induced protein 44-like |
C00002725
|
2844 | GPR21 | G protein-coupled receptor 21 |
C00002725
|
2745 | GLRX, GRX, GRX1 | glutaredoxin (thioltransferase) (EC:1.8.4.1) |
C00002725
|
2535 | FZD2, Fz2, fz-2, fzE2, hFz2 | frizzled family receptor 2 |
C00002725
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00002725
|
22801 | ITGA11, HsT18964 | integrin, alpha 11 |
C00002725
|
3727 | JUND, AP-1 | jun D proto-oncogene |
C00002725
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00002725
|
10186 | LHFP | lipoma HMGIC fusion partner (EC:3.6.5.4) |
C00002725
|
29995 | LMCD1 | LIM and cysteine-rich domains 1 |
C00002725
|
29967 | LRP12, ST7 | low density lipoprotein receptor-related protein 12 |
C00002725
|
4049 | LTA, LT, TNFB, TNFSF1 | lymphotoxin alpha |
C00002725
|
79917 | MAGIX, JM10, PDZX | MAGI family member, X-linked |
C00002725
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00002725
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00002725
|
8550 | MAPKAPK5, MAPKAP-K5, MK-5, MK5, PRAK | mitogen-activated protein kinase-activated protein kinase 5 (EC:2.7.11.1) |
C00002725
|
57787 | MARK4, MARK4L, MARK4S, MARKL1, MARKL1L, PAR-1D | MAP/microtubule affinity-regulating kinase 4 (EC:2.7.11.1) |
C00002725
|
4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00002725
|
4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00002725
|
4599 | MX1, IFI-78K, IFI78, MX, MxA | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
C00002725
|
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00002725
|
100132406 | NBPF10, AB6, AG1, NBPF9 | neuroblastoma breakpoint family, member 10 |
C00002725
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00002725
|
2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00002725
|
22981 | NINL, NLP, dJ691N24.1 | ninein-like |
C00002725
|
4854 | NOTCH3, CADASIL, CASIL, IMF2 | notch 3 |
C00002725
|
2263 | FGFR2, BBDS, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 | fibroblast growth factor receptor 2 (EC:2.7.10.1) |
C00002725
|
56666 | PANX2, PX2, hPANX2 | pannexin 2 |
C00002725
|
5140 | PDE3B, HcGIP1, cGIPDE1 | phosphodiesterase 3B, cGMP-inhibited (EC:3.1.4.17) |
C00002725
|
7262 | PHLDA2, BRW1C, BWR1C, HLDA2, IPL, TSSC3 | pleckstrin homology-like domain, family A, member 2 |
C00002725
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00002725
|
9103 | FCGR2C, CD32, CD32C, CDW32, FCG2, FCRIIC, IGFR2 | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) |
C00002725
|
5447 | POR, CPR, CYPOR, P450R | P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
C00002725
|
8496 | PPFIBP1, L2, SGT2, hSGT2, hSgt2p | PTPRF interacting protein, binding protein 1 (liprin beta 1) |
C00002725
|
5514 | PPP1R10, CAT53, FB19, PNUTS, PP1R10, R111, p99 | protein phosphatase 1, regulatory subunit 10 |
C00002725
|
11107 | PRDM5, BCS2, PFM2 | PR domain containing 5 |
C00002725
|
146760 | RTN4RL1, NGRH2, NgR3 | reticulon 4 receptor-like 1 |
C00002725
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00002725
|
6444 | SGCD, 35DAG, CMD1L, DAGD, SG-delta, SGCDP, SGD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
C00002725
|
6563 | SLC14A1, HUT11, HsT1341, JK, RACH1, RACH2, UT-B1, UT1, UTE | solute carrier family 14 (urea transporter), member 1 |
C00002725
|
6506 | SLC1A2, EAAT2, GLT-1 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
C00002725
|
115111 | SLC26A7, SUT2 | solute carrier family 26 (anion exchanger), member 7 |
C00002725
|
114134 | SLC2A13, HMIT | solute carrier family 2 (facilitated glucose transporter), member 13 |
C00002725
|
11046 | SLC35D2, HFRC1, SQV7L, UGTrel8, hfrc | solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2 |
C00002725
|
23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00002725
|
6546 | SLC8A1, NCX1 | solute carrier family 8 (sodium/calcium exchanger), member 1 |
C00002725
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00002725
|
28966 | SNX24, PRO1284 | sorting nexin 24 |
C00002725
|
9295 | SRSF11, NET2, SFRS11, dJ677H15.2, p54 | serine/arginine-rich splicing factor 11 |
C00002725
|
2150 | F2RL1, GPR11, PAR2 | coagulation factor II (thrombin) receptor-like 1 |
C00002725
|
27067 | STAU2, 39K2, 39K3 | staufen double-stranded RNA binding protein 2 |
C00002725
|
8428 | STK24, MST3, MST3B, STE20, STK3 | serine/threonine kinase 24 (EC:2.7.11.1) |
C00002725
|
51684 | SUFU, PRO1280, SUFUH, SUFUXL | suppressor of fused homolog (Drosophila) |
C00002725
|
6915 | TBXA2R, BDPLT13, TXA2-R | thromboxane A2 receptor |
C00002725
|
7041 | TGFB1I1, ARA55, HIC-5, HIC5, TSC-5 | transforming growth factor beta 1 induced transcript 1 |
C00002725
|
55258 | THNSL2, SOFAT, THS2, TSH2 | threonine synthase-like 2 (S. cerevisiae) (EC:4.2.3.-) |
C00002725
|
2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00002725
|
27242 | TNFRSF21, BM-018, CD358, DR6 | tumor necrosis factor receptor superfamily, member 21 |
C00002725
|
55840 | EAF2, BM040, TRAITS, U19 | ELL associated factor 2 |
C00002725
|
83658 | DYNLRB1, BITH, BLP, DNCL2A, DNLC2A, ROBLD1 | dynein, light chain, roadblock-type 1 |
C00002725
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00002725
|
7273 | TTN, CMD1G, CMH9, CMPD4, EOMFC, HMERF, LGMD2J, MYLK5, TMD | titin (EC:2.7.11.1) |
C00002725
|
1848 | DUSP6, HH19, MKP3, PYST1 | dual specificity phosphatase 6 (EC:3.1.3.16 3.1.3.48) |
C00002725
|
7321 | UBE2D1, E2(17)KB1, SFT, UBC4/5, UBCH5, UBCH5A | ubiquitin-conjugating enzyme E2D 1 (EC:6.3.2.19) |
C00002725
|
7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) |
C00002725
|
7374 | UNG, DGU, HIGM4, HIGM5, UDG, UNG1, UNG15, UNG2 | uracil-DNA glycosylase (EC:3.2.2.27) |
C00002725
|
1789 | DNMT3B, ICF, ICF1, M.HsaIIIB | DNA (cytosine-5-)-methyltransferase 3 beta (EC:2.1.1.37) |
C00002725
|
340481 | ZDHHC21, 9130404H11Rik, DHHC-21, DHHC21, DNZ1, HSPC097 | zinc finger, DHHC-type containing 21 (EC:2.3.1.225) |
C00002725
|
79973 | ZNF442 | zinc finger protein 442 |
C00002725
|
440515 | ZNF506 | zinc finger protein 506 |
C00002725
|
51193 | ZNF639, 6230400O18Rik, ANC-2H01, ANC_2H01, ZASC1 | zinc finger protein 639 |
C00002725
|
2039 | DMTN, DMT, EPB49 | dematin actin binding protein |
C00002725
|
56616 | DIABLO, DFNA64, SMAC | diablo, IAP-binding mitochondrial protein |
C00002725
|
54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00002725
|
1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00002725
|
1581 | CYP7A1, CP7A, CYP7, CYPVII | cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) |
C00002725
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002725
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00002725
|
1399 | CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
C00002725
|
51232 | CRIM1, CRIM-1, S52 | cysteine rich transmembrane BMP regulator 1 (chordin-like) |
C00002725
|
1294 | COL7A1, EBD1, EBDCT, EBR1 | collagen, type VII, alpha 1 |
C00002725
|
4848 | CNOT2, CDC36, NOT2, NOT2H | CCR4-NOT transcription complex, subunit 2 |
C00002725
|
1196 | CLK2, hCLK2 | CDC-like kinase 2 (EC:2.7.12.1) |
C00002725
|
1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00002725
|
994 | CDC25B | cell division cycle 25B (EC:3.1.3.48) |
C00002725
|
91057 | CCDC34, NY-REN-41, RAMA3 | coiled-coil domain containing 34 |
C00002725
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002725
|
834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) |
C00002725
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00002725
|
55973 | BCAP29, BAP29 | B-cell receptor-associated protein 29 |
C00002725
|
23250 | ATP11A, ATPIH, ATPIS | ATPase, class VI, type 11A (EC:3.6.3.1) |
C00002725
|
57636 | ARHGAP23 | Rho GTPase activating protein 23 |
C00002725
|
57679 | ALS2, ALS2CR6, ALSJ, IAHSP, PLSJ | amyotrophic lateral sclerosis 2 (juvenile) |
C00002725
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00029961
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00029961
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00029961
|
133 | ADM, AM | adrenomedullin |
C00002725
|
132 | ADK, AK | adenosine kinase (EC:2.7.1.20) |
C00002725
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00029961
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00029961
|
8745 | ADAM23, MDC-3, MDC3 | ADAM metallopeptidase domain 23 |
C00002725
|
145447 | ABHD12B, BEM46L3, C14orf29, c14_5314 | abhydrolase domain containing 12B |
C00002725
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00002725
|
3077 | HFE, HFE1, HH, HLA-H, MVCD7, TFQTL2 | hemochromatosis |
C00002725
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00002713
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00002713
|
10850 | CCL27, ALP, CTACK, CTAK, ESKINE, ILC, PESKY, SCYA27 | chemokine (C-C motif) ligand 27 |
C00000620
|
9021 | SOCS3, ATOD4, CIS3, Cish3, SOCS-3, SSI-3, SSI3 | suppressor of cytokine signaling 3 |
C00000620
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000620
|
7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein |
C00000620
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002713
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00029528
|
597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 |
C00031531
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002713
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00031531
|
8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00031531
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00031531
|
9020 | MAP3K14, FTDCR1B, HS, HSNIK, NIK | mitogen-activated protein kinase kinase kinase 14 (EC:2.7.11.25) |
C00031531
|
7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A |
C00031531
|
8717 | TRADD, Hs.89862 | TNFRSF1A-associated via death domain |
C00031531
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00031531
|
7186 | TRAF2, MGC:45012, TRAP, TRAP3 | TNF receptor-associated factor 2 |
C00031531
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00031531
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00032635
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00032635
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00032635
|
6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00032635
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00032635
|
5862 | RAB2A, LHX, RAB2 | RAB2A, member RAS oncogene family |
C00032635
|
9 | NAT1, AAC1, MNAT, NAT-1, NATI | N-acetyltransferase 1 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
C00007259
|
10 | NAT2, AAC2, NAT-2, PNAT | N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
C00007259
|
6799 | SULT1A2, HAST4, P-PST, ST1A2, STP2, TSPST2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) |
C00007259
|
47 | ACLY, ACL, ATPCL, CLATP | ATP citrate lyase (EC:2.3.3.8) |
C00002724
|
358 | AQP1, AQP-CHIP, CHIP28, CO | aquaporin 1 |
C00002724
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00002724
|
4779 | NFE2L1, LCR-F1, NRF1, TCF11 | nuclear factor, erythroid 2-like 1 |
C00032635
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002724
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002724
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002724
|
4512 | COX1, COI, MTCO1, MT-CO1 | cytochrome c oxidase subunit I |
C00002724
|
114757 | CYGB, HGB, STAP | cytoglobin |
C00002724
|
1830 | DSG3, CDHF6, PVA | desmoglein 3 |
C00002724
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002724
|
2200 | FBN1, ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFS1, OCTD, SGS, SSKS, WMS, WMS2 | fibrillin 1 |
C00002724
|
2201 | FBN2, CCA, DA9 | fibrillin 2 |
C00002724
|
2246 | FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1 | fibroblast growth factor 1 (acidic) |
C00002724
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00002724
|
3036 | HAS1, HAS | hyaluronan synthase 1 (EC:2.4.1.212) |
C00002724
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00002724
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002724
|
3852 | KRT5, CK5, DDD, DDD1, EBS2, K5, KRT5A | keratin 5 |
C00002724
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00002724
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002724
|
8985 | PLOD3, LH3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) |
C00002724
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00032635
|
5886 | RAD23A, HHR23A, HR23A | RAD23 homolog A (S. cerevisiae) |
C00002724
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002724
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00002724
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00002724
|
7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 |
C00002724
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00002724
|
7306 | TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN | tyrosinase-related protein 1 (EC:1.14.18.-) |
C00002724
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00032635
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00001408
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001408
|
664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00001408
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001408
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001408
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001408
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00001408
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001408
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00032635
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001408
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001408
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001408
|
4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00001408
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00001408
|
4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00001408
|
5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00001408
|
5998 | RGS3, C2PA, RGP3 | regulator of G-protein signaling 3 |
C00001408
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00001408
|
10922 | FASTK, FAST | Fas-activated serine/threonine kinase (EC:2.7.11.8) |
C00032635
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001408
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001408
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001408
|
9016 | SLC25A14, BMCP1, UCP5 | solute carrier family 25 (mitochondrial carrier, brain), member 14 |
C00001408
|
37618 |
C00032635
|
||
993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) |
C00032635
|
6319 | SCD, FADS5, MSTP008, SCD1, SCDOS | stearoyl-CoA desaturase (delta-9-desaturase) (EC:1.14.19.1) |
C00002743
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00001408
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002743
|
5742 | PTGS1, COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1, PGHS1, PHS1, PTGHS | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002743
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00001408
|
23460 | ABCA6, EST155051 | ATP-binding cassette, sub-family A (ABC1), member 6 |
C00000619
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000619
|
55114 | ARHGAP17, MST066, MST110, MSTP038, MSTP066, MSTP110, NADRIN, PP367, PP4534, RICH1, RICH1B, WBP15 | Rho GTPase activating protein 17 |
C00000619
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00000619
|
567 | B2M | beta-2-microglobulin |
C00000619
|
9774 | BCLAF1, BTF, bK211L9.1 | BCL2-associated transcription factor 1 |
C00000619
|
654 | BMP6, VGR, VGR1 | bone morphogenetic protein 6 |
C00000619
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00000619
|
57102 | C12orf4 | chromosome 12 open reading frame 4 |
C00000619
|
10203 | CALCRL, CGRPR, CRLR | calcitonin receptor-like |
C00000619
|
6357 | CCL13, CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 | chemokine (C-C motif) ligand 13 |
C00000619
|
6363 | CCL19, CKb11, ELC, MIP-3b, MIP3B, SCYA19 | chemokine (C-C motif) ligand 19 |
C00000619
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00000619
|
6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00000619
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00000619
|
729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00000619
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00000619
|
1236 | CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1 | chemokine (C-C motif) receptor 7 |
C00000619
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00000619
|
1514 | CTSL, CATL, CTSL1, MEP | cathepsin L (EC:3.4.22.15) |
C00000619
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00000619
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000619
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00000619
|
1736 | DKC1, CBF5, DKC, DKCX, NAP57, NOLA4, XAP101 | dyskeratosis congenita 1, dyskerin |
C00000619
|
9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00000619
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00000619
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00000619
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00000619
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00000619
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00000619
|
1876 | E2F6, E2F-6 | E2F transcription factor 6 |
C00000619
|
1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00000619
|
133418 | EMB | embigin |
C00000619
|
2162 | F13A1, F13A | coagulation factor XIII, A1 polypeptide (EC:2.3.2.13) |
C00000619
|
26268 | FBXO9, FBX9, NY-REN-57, VCIA1, dJ341E18.2 | F-box protein 9 |
C00000619
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00000619
|
644076 | GLYCAM1 | glycosylation dependent cell adhesion molecule 1 (pseudogene) |
C00000619
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000619
|
2994 | GYPB, CD235b, GPB, GPB.NY, GYPHe.NY, GpMiIII, HGpMiIII, HGpMiVI, HGpMiX, MNS, PAS-3, SS | glycophorin B (MNS blood group) |
C00000619
|
54497 | HEATR5B | HEAT repeat containing 5B |
C00000619
|
3106 | HLA-B, AS, HLAB, SPDA1 | major histocompatibility complex, class I, B |
C00000619
|
220988 | HNRNPA3, 2610510D13Rik, D10S102, FBRNP, HNRPA3 | heterogeneous nuclear ribonucleoprotein A3 |
C00000619
|
3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00000619
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00000619
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00000619
|
26034 | IPCEF1, PIP3-E, RP3-402L9.2 | interaction protein for cytohesin exchange factors 1 |
C00000619
|
3655 | ITGA6, CD49f, ITGA6B, VLA-6 | integrin, alpha 6 |
C00000619
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000619
|
3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00000619
|
3759 | KCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3 | potassium inwardly-rectifying channel, subfamily J, member 2 |
C00000619
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00000619
|
28985 | MCTS1, MCT-1, MCT1 | malignant T cell amplified sequence 1 |
C00000619
|
51318 | MRPL35, L35mt, MRP-L35 | mitochondrial ribosomal protein L35 |
C00000619
|
58475 | MS4A7, 4SPAN2, CD20L4, CFFM4, MS4A8 | membrane-spanning 4-domains, subfamily A, member 7 |
C00000619
|
4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00000619
|
4602 | MYB, Cmyb, c-myb, c-myb_CDS, efg | v-myb avian myeloblastosis viral oncogene homolog |
C00000619
|
10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00000619
|
4927 | NUP88 | nucleoporin 88kDa |
C00000619
|
10606 | PAICS, ADE2, ADE2H1, AIRC, PAIS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) |
C00000619
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000619
|
8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00000619
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000619
|
10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00000619
|
5733 | PTGER3, EP3, EP3-I, EP3-II, EP3-III, EP3-IV, EP3e, PGE2-R | prostaglandin E receptor 3 (subtype EP3) |
C00000619
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00000619
|
6157 | RPL27A, L27A | ribosomal protein L27a |
C00000619
|
50484 | RRM2B, MTDPS8A, MTDPS8B, P53R2 | ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) |
C00000619
|
6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00000619
|
6383 | SDC2, CD362, HSPG, HSPG1, SYND2 | syndecan 2 |
C00000619
|
55752 | SEPT11 | septin 11 |
C00000619
|
6504 | SLAMF1, CD150, CDw150, SLAM | signaling lymphocytic activation molecule family member 1 |
C00000619
|
117247 | SLC16A10, MCT10, PRO0813, TAT1 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
C00000619
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00000619
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000619
|
6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00000619
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000619
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000619
|
7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00000619
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000619
|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000619
|
7358 | UGDH, GDH, UDP-GlcDH, UDPGDH, UGD | UDP-glucose 6-dehydrogenase (EC:1.1.1.22) |
C00000619
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000619
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000619
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000619
|
7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00000619
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00000619
|
7709 | ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67 | zinc finger and BTB domain containing 17 |
C00000619
|
8694 | DGAT1, ARAT, ARGP1, DGAT | diacylglycerol O-acyltransferase 1 (EC:2.3.1.20 2.3.1.76) |
C00007462
|
3172 | HNF4A, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha, MODY, MODY1, NR2A1, NR2A21, TCF, TCF14 | hepatocyte nuclear factor 4, alpha |
C00007462
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00007462
|
6462 | SHBG, ABP, SBP, TEBG | sex hormone-binding globulin |
C00007462
|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001435
|
213 | ALB, PRO0883, PRO0903, PRO1341 | albumin |
C00037855
|
1230 | CCR1, CD191, CKR-1, CKR1, CMKBR1, HM145, MIP1aR, SCYAR1 | chemokine (C-C motif) receptor 1 |
C00037855
|
2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00037855
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00037855
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00037855
|
3937 | LCP2, SLP-76, SLP76 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
C00037855
|
4968 | OGG1, HMMH, HOGG1, MUTM, OGH1 | 8-oxoguanine DNA glycosylase (EC:4.2.99.18) |
C00037855
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00037855
|
7042 | TGFB2, LDS4, TGF-beta2 | transforming growth factor, beta 2 |
C00037855
|
7049 | TGFBR3, BGCAN, betaglycan | transforming growth factor, beta receptor III |
C00037855
|
7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00037855
|
7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 |
C00037855
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#614279 | 46,xy sex reversal 8; srxy8 |
P17516
P52895 |
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#606798 | Blepharospasm, benign essential |
P21918
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P18054
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#606703 | Dyskinesia, familial, with facial myokymia; fdfm |
O95622
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P08581
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
Q06124
|
#151100 | Leopard syndrome 1 |
Q06124
|
#608232 | Leukemia, chronic myeloid; cml |
P00519
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#609048 | Melanoma, cutaneous malignant, susceptibility to, 3; cmm3 |
P11802
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#156250 | Metachondromatosis; metcds |
Q06124
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#601492 | Mucopolysaccharidosis, type ix; mps9 |
Q12794
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#254210 | Myasthenic syndrome, congenital, associated with episodic apnea |
P28329
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254500 | Myeloma, multiple |
P24385
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#163950 | Noonan syndrome 1; ns1 |
Q06124
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#613684 | Rubinstein-taybi syndrome 2; rsts2 |
Q09472
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
|
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
P00519
(related)
P00519 (marker) Q01196 (related) Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
P00519
(related)
P00519 (marker) P04637 (related) Q01196 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P24385 (related) P24385 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P24385 (related) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P11802 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P11802 (related) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P24385 (related) P24385 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P24385 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
P24385 (related) |
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
P24385 (related) |
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P11802 (related) P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
P24385 (marker) |
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00559 | von Hippel-Lindau syndrome |
P24385
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00770 | Congenital myasthenic syndrome |
P28329
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00409 | Type II diabetes mellitus |
P49286
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00523 | Noonan syndrome and related disorders |
Q06124
(related)
|
H01018 | Metachondromatosis |
Q06124
(related)
|
H00504 | Rubinstein-Taybi syndrome |
Q09472
(related)
|
H00133 | Mucopolysaccharidosis type IX (MPS9) |
Q12794
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
Q12794
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D008545 | Melanoma |
C00002743
C00002725 C00029961 C00000152 C00002724 C00000619 |
D056486 | Drug-Induced Liver Injury |
C00002713
C00002776 C00002724 C00000619 C00037855 |
D000647 | Amnesia |
C00002752
C00029533 C00002776 C00002724 |
D017449 | Dermatitis, Allergic Contact |
C00002725
C00042390 C00000620 C00000619 |
D007022 | Hypotension |
C00002713
C00002740 C00001408 C00001435 |
D001943 | Breast Neoplasms |
C00002712
C00000619 C00037855 |
D006930 | Hyperalgesia |
C00002725
C00001408 C00000619 |
D007249 | Inflammation |
C00002743
C00002713 C00000619 |
D006973 | Hypertension |
C00001408
C00001435 |
D008107 | Liver Diseases |
C00032635
C00002713 |
D001919 | Bradycardia |
C00002713
C00002740 |
D002286 | Carcinoma, Ehrlich Tumor |
C00002713
C00031531 |
D003877 | Dermatitis, Contact |
C00002713
C00000619 |
D010300 | Parkinson Disease |
C00001408
C00000619 |
D009410 | Nerve Degeneration |
C00001408
C00000619 |
D020734 | Parkinsonian Disorders |
C00001408
C00029504 |
D008113 | Liver Neoplasms |
C00002713
C00002740 |
D009362 | Neoplasm Metastasis |
C00002713
C00000619 |
D006943 | Hyperglycemia |
C00032635
C00002725 |
D013276 | Stomach Ulcer |
C00002713
C00000619 |
D013927 | Thrombosis |
C00002713
C00002725 |
D006528 | Carcinoma, Hepatocellular |
C00002740
C00002725 |
D006948 | Hyperkinesis |
C00001408
C00029504 |
D012640 | Seizures |
C00001408
C00029504 |
D006331 | Heart Diseases |
C00001408
C00000619 |
D002375 | Catalepsy |
C00001408
C00029504 |
D009336 | Necrosis |
C00002724
C00001408 |
D003384 | Coxsackievirus Infections |
C00002725
C00029961 |
D013226 | Status Epilepticus |
C00001408
C00029504 |
D013610 | Tachycardia |
C00001408
C00001435 |
D001862 | Bone Resorption |
C00000010
C00030167 |
D004487 | Edema |
C00002725
C00002776 |
D007859 | Learning Disorders |
C00029533
C00001408 |
D014581 | Urticaria |
C00002725
C00000619 |
D011041 | Poisoning |
C00001435
C00037855 |
D012481 | Salmonella Infections, Animal |
C00002725
C00000619 |
D010146 | Pain |
C00002725
C00000619 |
D020301 | Vasospasm, Intracranial |
C00001408
|
D012478 | Salmonella Food Poisoning |
C00002725
|
D006984 | Hypertrophy |
C00002725
|
D012678 | Sensation Disorders |
C00002725
|
D006470 | Hemorrhage |
C00002725
|
D014735 | Vibrio Infections |
C00002725
|
D004890 | Erythema |
C00002725
|
D003924 | Diabetes Mellitus, Type 2 |
C00002725
|
D003921 | Diabetes Mellitus, Experimental |
C00002725
|
D000860 | Anoxia |
C00002776
|
D001930 | Brain Injuries |
C00002776
|
D006937 | Hypercholesterolemia |
C00002724
|
D006951 | Hyperlipoproteinemias |
C00002724
|
D015228 | Hypertriglyceridemia |
C00002724
|
D052456 | Hypoalphalipoproteinemias |
C00002724
|
D003371 | Cough |
C00002725
|
D015431 | Weight Loss |
C00002724
|
D058186 | Acute Kidney Injury |
C00001408
|
D000788 | Angina Pectoris, Variant |
C00001408
|
D001145 | Arrhythmias, Cardiac |
C00001408
|
D001480 | Basal Ganglia Diseases |
C00001408
|
D002303 | Cardiac Output, Low |
C00001408
|
D003110 | Colonic Neoplasms |
C00002725
|
D002389 | Catatonia |
C00001408
|
D002493 | Central Nervous System Diseases |
C00001408
|
D019970 | Cocaine-Related Disorders |
C00001408
|
D004342 | Drug Hypersensitivity |
C00001408
|
D062787 | Drug Overdose |
C00001408
|
D004409 | Dyskinesia, Drug-Induced |
C00001408
|
D004417 | Dyspnea |
C00001408
|
D004802 | Eosinophilia |
C00001408
|
D006323 | Heart Arrest |
C00001408
|
D002471 | Cell Transformation, Neoplastic |
C00002725
|
D006333 | Heart Failure |
C00001408
|
D006556 | Heroin Dependence |
C00001408
|
D008114 | Liver Neoplasms, Experimental |
C00002740
|
D010243 | Paralysis |
C00002713
|
D007008 | Hypokalemia |
C00001408
|
D018476 | Hypokinesia |
C00001408
|
D007024 | Hypotension, Orthostatic |
C00001408
|
D008133 | Long QT Syndrome |
C00001408
|
D020149 | Manganese Poisoning |
C00001408
|
D048629 | Micronuclei, Chromosome-Defective |
C00001408
|
D017202 | Myocardial Ischemia |
C00001408
|
D009205 | Myocarditis |
C00001408
|
D005767 | Gastrointestinal Diseases |
C00002713
|
D009422 | Nervous System Diseases |
C00001408
|
D009846 | Oliguria |
C00001408
|
D050171 | Dyslipidemias |
C00032635
|
D003928 | Diabetic Nephropathies |
C00032635
|
D010547 | Persistent Fetal Circulation Syndrome |
C00001408
|
D011595 | Psychomotor Agitation |
C00001408
|
D012127 | Respiratory Distress Syndrome, Newborn |
C00001408
|
D009203 | Myocardial Infarction |
C00002743
|
D012769 | Shock |
C00001408
|
D012770 | Shock, Cardiogenic |
C00001408
|
D012772 | Shock, Septic |
C00001408
|
D008106 | Liver Cirrhosis, Experimental |
C00002743
|
D013375 | Substance Withdrawal Syndrome |
C00001408
|
D050197 | Atherosclerosis |
C00002743
|
D013616 | Tachycardia, Sinus |
C00001408
|
D016171 | Torsades de Pointes |
C00001408
|
D014202 | Tremor |
C00001408
|
D011655 | Pulmonary Embolism |
C00002725
|
D018487 | Ventricular Dysfunction, Left |
C00001408
|
D003875 | Drug Eruptions |
C00000619
|
D006461 | Hemolysis |
C00000619
|
D006967 | Hypersensitivity |
C00000619
|
D009361 | Neoplasm Invasiveness |
C00000619
|
D009374 | Neoplasms, Experimental |
C00000619
|
D009389 | Neovascularization, Pathologic |
C00000619
|
D010149 | Pain, Postoperative |
C00000619
|
D011833 | Radiation Injuries, Experimental |
C00000619
|
D012878 | Skin Neoplasms |
C00000619
|
D013035 | Spasm |
C00000619
|
D013203 | Staphylococcal Infections |
C00000619
|
D013274 | Stomach Neoplasms |
C00000619
|
D002583 | Uterine Cervical Neoplasms |
C00000619
|
D001927 | Brain Diseases |
C00029504
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00029504
|
D006816 | Huntington Disease |
C00029504
|
D010302 | Parkinson Disease, Secondary |
C00029504
|
C537537 | Segawa syndrome, autosomal recessive |
C00029504
|
D019956 | Stereotypic Movement Disorder |
C00029504
|
D011605 | Psychoses, Substance-Induced |
C00001419
|
D009202 | Cardiomyopathies |
C00001435
|
D002543 | Cerebral Hemorrhage |
C00001435
|
D002637 | Chest Pain |
C00001435
|
D008881 | Migraine Disorders |
C00001435
|
D015878 | Mydriasis |
C00001435
|
D002252 | Carbon Tetrachloride Poisoning |
C00002743
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00037855
|
D034381 | Hearing Loss |
C00037855
|
D055370 | Lung Injury |
C00037855
|
D008175 | Lung Neoplasms |
C00037855
|
D015674 | Mammary Neoplasms, Animal |
C00037855
|
D011014 | Pneumonia |
C00037855
|